| iNOS | inducible nitric oxide synthase |
| COX-2 | cyclooxygenase |
| SOCS-3 | suppressor of cytokine signaling 3 |
| AMPKα | (AMP)-activated protein kinase α |
| PKC | protein kinase C |
| JNK | c-Jun N terminal kinase |
| ERK | extracellular-signal-regulated kinase |
| MAPK | mitogen-activated protein kinase |
| TNF- α | tumor necrosis factor α |
| INF-γ | interferon γ |
| IL-1β | interleukin 1β |
| MCP-1 | monocyte chemoattractant protein-1 |
| STAT-1 | signal transducer and activator of transcription-1 |
| PI3K/Akt | phosphatidylinositol-3 kinase/Akt |
| ER | estrogen receptor |
| ROS | reactive oxygen species |
| MDA | malondialdehyde |
| BACE | β-Site amyloid precursor protein (APP) cleaving enzyme |
| APP | amyloid precursor protein |
| GSK-3β | glycogen synthase kinase 3β |
| PPAR-γ | peroxisome proliferator-activated receptor gamma |
| AchE | acetylcholinesterase |
| RIP2 | receptor interacting protein-2 |
| NF-κB | nuclear factor-κB |
| MMP-9 | matrix metallopeptidase 9 |
| SOD | superoxide dismutase |
| GSH | glutathione |
| Nrf-2/ARE | nuclear factor E2-related factor 2/ antioxidant response element |
| HO-1 | hemoxygenase-1 |
| NQO-1 | NAD(P)H quinone dehydrogenase1 |
| TBARS | thiobarbituric acid-reactive substances |
| BDNF | brain-derived neurotrophic factor |
| TrkB | tropomyosin-related kinase B |
| GRP78 | glucose-regulated protein |
| Foxp3 | forkhead box P3 |
| DOPAC | dihydroxyphenylacetic acid |
| HVA | homovanillic acid |
| TH | tyrosine hydroxylase |
| CHIP | C terminus Hsp70 interacting protein |
| LPO | lipid peroxidation |
| GDNF | glial cell line-derived neurotrophic factor |
| HIF1a | hypoxia inducible factor1a |
| VEGF | vascular endothelial growth factor |
| 5-HT | 5-hydroxytryptamine |
| GFAP | glial fibrillary acidic protein |
| 6-OHDA | 6-hydroxydopamine |
| ICV-STZ | intracerebroventricular-streptozotocine |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| LPS | lipopolysaccharide |
| MeHg | methyl mercury |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MPP+ | 1-methyl-4-phenylpyridinium |
| pMCAO | permanent middle cerebral artery occlusion |
| tMCAO | transient middle cerebral artery occlusion |
| EAE | experimental autoimmune encephalomyelitis |